Tambotatug Pelitecan Delivers a Major Survival Gain in Relapsed SCLC: TAISHAN-302 Establishes B7-H3 as a Therapeutic Target
FDA Approves Floretyrosine F 18 for PET Imaging in Glioma
Cancer Immunotherapy: 2016 vs 2026
Trastuzumab Deruxtecan Improves PFS in First-Line HER2-Mutant NSCLC in DESTINY-Lung04
Jose Pacheco: Tambotatug Pelitecan Shows Superior Survival in Small Cell Lung Cancer
ACT 4 Children Calls for Global Action and Healthcare Equity During Childhood Cancer Awareness Month
Diego A. Díaz-García: PAPILLON Delivers New Overall Survival Data in EGFR Ex20ins NSCLC
10 Must-Read Posts In GU Oncology This Week
The EORTC Cutaneous Lymphoma Tumour Group Annual Meeting 2026 will take place from October 8–10, 2026, at the Colosseum Berlin in Berlin, Germany. The meeting will bring together clinicians, pathologists, scientists, researchers, and healthcare professionals from Europe and beyond to discuss current developments in cutaneous lymphomas. The scientific programme will focus on cutaneous lymphomas, inflammatory […]
